A Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104).

Trial Profile

A Study of SCH 900518 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C (Protocol No. P05104).

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2014

At a glance

  • Drugs Narlaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin; Ritonavir
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms NEXT-1
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 26 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Nov 2009 Interim results presented at the American Association for the Study of Liver Diseases (AASLD) 2009 Annual Meeting, according to a Schering-Plough media release.
    • 30 Oct 2009 Interim results were presented at AASID 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top